PDGFRB and metastatic melanoma: Although experimental studies demonstrated the involvement of PDGF/PDGFR pathway in melanoma progression and metastasis, this issue deserves further investigations, because no clinical benefits were found in clinical trials with PDGFR inhibitors in metastatic melanoma [92].